nanolc - OmicsDI

Show results for

Proteomics (4145)
Unknown (365)
Metabolomics (21)
Other (6)
Genomics (3)
Transcriptomics (1)

Organisms

Rattus norvegicus (3959)
Homo sapiens (3959)
Mus musculus (3959)
Shigella flexneri (3958)
Allexis (3958)
Shigella (3958)
Schizosaccharomyces pombe (3957)
Homo sapiens (45)
cellular organisms (33)
Mus musculus (22)
Ruegeria sp. AD91A (1)
Vibrio azureus (1)
Pseudomonas abyssi (1)
Bacillus pacificus (1)
Bacillus infantis (1)
Aurantiacibacter marinus (1)
Pinus massoniana (1)
Manihot esculenta (1)
Staphylococcus aureus (1)
Rattus norvegicus (1)
Mycobacterium tuberculosis variant bovis BCG (1)
CL:0000066 (1)
Xenopus laevis (1)
Sus scrofa (1)
Cryptococcus neoformans (1)
Rattus (1)
Oryza sativa (1)
Rattus rattus (1)
Triticum (1)
Hordeum vulgare (1)

Organisms

Homo sapiens (1)

Repository

pride (3959)
jPOST (81)
MassIVE (71)
iProX (20)
MetaboLights (15)
PeptideAtlas (7)
GNPS (6)
GPMDB (4)
PanoramaPublic (4)
PAXDB (4)
ENA (2)
biostudies-arrayexpress (1)
EGA (1)
NODE (1)

Tissue

Cell culture (761)
Epithelial cell (247)
Brain (239)
Liver (127)
Plant cell (113)
Blood plasma (103)
Colon (88)
Leaf (85)
Permanent cell line cell (84)
Kidney (83)
Blood (71)
Lung (65)
Fibroblast (64)
Heart (62)
Blood serum (61)
Cell suspension culture (61)
T cell (56)
Macrophage (55)
Blood cell (53)
Root (49)
HeLa cell (49)
Embryo (44)
Embryonic stem cell (43)
Stem cell (40)
Skin (38)
Whole body (35)
Saliva (35)
Hepatocyte (33)
Cerebrospinal fluid (32)
Plasma (1)

Disease

Breast cancer (87)
Disease free (85)
Colon cancer (81)
Cervix carcinoma (32)
Wounds and Injuries (32)
Acute leukemia (31)
Parkinson's disease (29)
Melanoma (26)
Alzheimer's disease (26)
Cardiovascular system disease (19)
Type 2 diabetes mellitus (19)
Lung cancer (17)
Lymphoma (16)
Brain cancer (16)
Brain glioblastoma multiforme (15)
Malignant neoplasm of ovary (15)
Plasmodium falciparum malaria (13)
Obesity (13)
Prostate adenocarcinoma (13)
Prostate cancer (11)
Glioblastoma (11)
Non-small cell lung carcinoma (10)
Neuroblastoma (10)
Cystic fibrosis (10)
Hepatocellular carcinoma (9)
Colorectal cancer (9)
Influenza (9)
Multiple myeloma (8)
Tuberculosis (8)
Not Available (4)

Technology Type

Mass Spectrometry (3959)
Shotgun proteomics (2146)
Bottom-up proteomics (702)
Affinity purification coupled with mass spectrometry proteomics (424)
Data-dependent acquisition (369)
Gel-based experiment (339)
SWATH MS (295)
Data-independent acquisition (160)
Top-down proteomics (136)
SRM/MRM (56)
Chemical cross-linking coupled with mass spectrometry proteomics (49)
Affinity proteomics (18)
All-ion fragmentation (17)
Mass spectrometry (13)
MSE (13)
DiaPASEF (12)
HDMSE (8)
Metaproteomics (6)
Glycoproteomics (5)
Proteogenomics (4)
Mass spectrometry imaging (4)
Gel-free quantification method (3)
Immunopeptidomics (3)
Mass spectrometry assay (2)
RNA mass spectrometry (2)
Gel-based quantification method (1)
Sodium dodecyl sulfate polyacrylamide gel electrophoresis (1)

Instrument Platform

Q Exactive (13)
Orbitrap Fusion (8)
Orbitrap Fusion Lumos (7)
Orbitrap Eclipse (6)
Orbitrap Exploris 480 (6)
Instrument (4)
LTQ Orbitrap XL ETD (4)
Q Exactive HF (3)
MaXis II (3)
LTQ Orbitrap Elite (3)
TimsTOF Pro (2)
TripleTOF 5600 (2)
Impact (2)
Impact II (2)
LTQ Orbitrap XL (2)
Orbitrap Exploris 240 (2)
Autoflex III TOF/TOF smartbeam (1)
QSTAR (1)
NanoLC-MS/MS (1)
Orbitrap Fusion Lumos Tribrid Mass Spectrometer (1)
MALDI Biotyper (1)
TimsTOF Ultra 2 (1)
2.Orbitrap Astral mass spectrometer coupled with a Vanquish Neo UHPLC system (Thermo Fisher Scientific) (1)
3. Tandem EASY-nanoLC1200 with Orbitrap Fusion Lumos (Thermo Fisher Scientific, MA, USA) (1)
1. Orbitrap melting fluorescence coupled to an EASY nanoLC 1200 system (Thermo Fisher Scientific, MA, USA) (1)
Xevo G2 Q-Tof (1)
Orbitrap Ascend (1)
Dionex UltiMate 3000 Rapid Separation nanoLC coupled to the Orbitrap Elite Mass Spectrometer (1)
6520A Quadrupole Time-of-Flight LC/MS (1)
Orbitrap Astral (1)

Publication Date

2022 (534)
2025 (500)
2026 (465)
2023 (452)
2021 (451)
2024 (404)
2020 (313)
2019 (290)
2018 (277)
2017 (159)
2016 (126)
2015 (95)
2014 (57)
2013 (16)
2005 (5)
2011 (3)
2012 (2)
2010 (2)
2008 (1)

UNIPROT ID/AC

A5C0R5_VITVI (2)
D7TBV3_VITVI (2)
F6HKB3_VITVI (2)
D7SVZ9_VITVI (2)
F6HNT7_VITVI (2)
F6HHN8_VITVI (2)
D7U187_VITVI (2)
F6HST5_VITVI (2)
A5ASC2_VITVI (2)
D7SRB4_VITVI (2)
D7UBN6_VITVI (2)
D7TZB7_VITVI (2)
D7U0C2_VITVI (2)
E0CT31_VITVI (2)
F6HLR7_VITVI (2)
F6HHD4_VITVI (2)
F6I0Z8_VITVI (2)
D7TCR2_VITVI (2)
F6H6C3_VITVI (2)
F6I115_VITVI (2)
F6GTG4_VITVI (2)
C5DB51_VITVI (2)
F6HMX8_VITVI (2)
D7TK50_VITVI (2)
D7TF52_VITVI (2)
D7TS66_VITVI (2)
F6HGH6_VITVI (2)
F6HHU0_VITVI (2)
F6H0X2_VITVI (2)
D7TTW7_VITVI (2)

CHEBI ID

CHEBI:16359 (4)
CHEBI:35038 (3)
CHEBI:15721 (3)
CHEBI:75342 (3)
CHEBI:28865 (3)
CHEBI:27432 (3)
CHEBI:143745 (2)
CHEBI:93213 (2)
CHEBI:182784 (2)
CHEBI:171846 (2)
CHEBI:143757 (2)
CHEBI:195271 (2)
CHEBI:167079 (2)
CHEBI:61724 (2)
CHEBI:15384 (2)
CHEBI:2376 (2)
CHEBI:18272 (2)
CHEBI:27465 (2)
CHEBI:37713 (2)
CHEBI:17969 (2)
CHEBI:18199 (2)
CHEBI:16077 (2)
CHEBI:69081 (2)
CHEBI:27781 (2)
CHEBI:84268 (2)
CHEBI:139138 (2)
CHEBI:17052 (2)
CHEBI:17994 (2)
CHEBI:34687 (2)
CHEBI:173703 (2)

Metabolite Name

Cholic acid (4)
Tris(2-butoxyethyl) phosphate (3)
Dibutyl phthalate (DBP) (2)
Lyso-PC(16:0) (2)
Alpha-linolenic acid|linolenic acid|(9Z,12Z,15Z)-octadeca-9,12,15-trienoic acid (2)
1-({[2-(2-furylmethyl)-5-methylpyrrolidinyl]amino}methylene)-7-[8-({[2-(2-fury lmethyl)pyrrolidinyl]amino}methylene)-1,6-dihydroxy-3-methyl-5-(methylethyl)-7 -oxo(2-naphthyl)]-3,8-dihydroxy-6-methyl-4-(methylethyl)naphthalen-2-one (2)
NCGC00385123-01_C22H30O6_7b,9-Dihydroxy-3-(hydroxymethyl)-1,1,6,8-tetramethyl-5-oxo-1,1a,1b,4,4a,5,7a,7b,8,9-decahydro-9aH-cyclopropa[3,4]benzo[1,2-e]azulen-9a-yl acetate (2)
(2S,3S,4S,5R,6R)-6-[[(3S,4S,6aR,6bS,8aR,9R,12aS,14bR)-9-hydroxy-4-(hydroxymethyl)-4,6a,6b,8a,11,11,14b-heptamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy]-5-[(2S,3R,4S,5R,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxyoxane-2-carboxylic acid (2)
5'-phosphoribosyl-N-formylglycinamide (2)
5'-Thymidylic acid (2)
N-Acetyl-D-glucosamine 1,6-bisphosphate (2)
O-phospho-D-serine (2)
Shikimate-3-phosphate (2)
Sedoheptulose 1,7-bisphosphate (2)
Acetyl-CoA (2)
SAICAR (2)
5'-Guanylic acid (2)
Guanosine 5'-diphosphate (2)
UDP-N-acetylmuramoyl-L-alanyl-D-gamma-glutamyl-6-carboxy-L-lysyl-D-alanyl-D-alanine (2)
Uridine diphosphate glucose (2)
Ribose 1,5-bisphosphate (2)
Glucose-1-phosphate (2)
Uridine triphosphate (2)
Adenosine diphosphate (2)
Uridylic acid (2)
Adenosine 5'-monophosphate (2)
Sedoheptulose 7-phosphate (2)
Glucose-6 phosphate (2)
2,6-Di-tert-butyl-4-hydroxymethylphenol (2)
UDP-GlcNAc (2)

First Public Date

2025 (1)
2014 (1)

Modification

Not available (16)
4-tetrahydrothiazine-3-carboxylic acid (12)
57.021464 (9)
15.994915 (8)
2x(15)N labeled L-lysine (8)
4x(15)N labeled L-arginine (7)
42.010565 (6)
N6-dimethyl-L-lysine (5)
-18.010565 (4)
-17.026549 (4)
N6 (4)
0.984016 (3)
57.02146 (2)
0.984 (2)
15.99491 (2)
+3amu) (2)
56.026215 (1)
43.00581 (1)
31.989829 (1)
79.966331 (1)
6-dioxaoctanediamine derivatized cysteine (1)
4x(2)H labeled dimethylated L-lysine (1)
4 (1)

Study type

Transcription profiling by array (1)

Release Date

2022 (34)
2020 (33)
2019 (29)
2018 (28)
2015 (28)
2021 (26)
2025 (25)
2016 (25)
2023 (24)
2017 (23)
2024 (19)
2014 (19)
2013 (13)
2012 (11)
2011 (11)
2010 (7)
2008 (4)
2009 (4)
2026 (3)

Lab affiliation

EDyP (92)
University of Vienna, Faculty of Chemistry, Department of Analytical Chemistry (46)
Amsterdam UMC, Vrije Universiteit Amsterdam, Medical Oncology, Cancer Center Amsterdam, OncoProteomics Laboratory, Amsterdam, Netherlands (40)
OncoProteomics Laboratory, Dept of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands (27)
Imperial College London (14)
General and molecular microbiology, Institute for chemistry and biology of the marine environment (ICBM), Carl von Ossietzky University of Oldenburg, Oldenburg, Germany (14)
Instituto de Investigaciones Sanitarias de Santiago de Compostela (14)
Cornell University (13)
TIGEM (12)
USDA-ARS (11)
ETH Zurich (10)
Wageningen University (10)
NARO Institute of Crop Science (9)
Vanderbilt University Proteomics Core (9)
CEA-Marcoule, ProGénoMIX platform, DRF-Li2D, 30207 Bagnols-sur-Cèze, France (9)
Paris-Saclay Institute of Neuroscience, Team Melki, CNRS, Gif-sur-Yvette, France (8)
Aarhus University, Denmark (8)
Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences (7)
DIVAS, University of Milan (7)
Mass Spectrometry/Proteomics Facility, Netherlands Cancer Institute, Amsterdam, Netherlands. (7)
Department of Convergence Medicine, Convergence Medicine Research Center/Biomedical Research Center, Asan Medical Center, Asan Institute for Life Sciences, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 05505, Republic of Korea. (7)
Center for Neuroscience and Cell Biology – University of Coimbra (7)
Univ. Bordeaux, Bordeaux Proteome, Bordeaux, France (7)
Head of the Curie Institute Mass Spectrometry Platform (7)
Head of Proteomics (7)
Plateforme Oncoprot, TBM-Core US 005, F-33000 Bordeaux, France (6)
Medical Proteomics Unit, Research Department, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand (6)
IGMM, CNRS, Université de Montpellier, Montpellier, France (5)
Research Unit for Molecular Medicine, Department of clinical Medicine, Aarhus University, Aarhus, Denmark (5)
Mass Spectrometry Facility, Department of Chemistry and Biochemistry, San Francisco State University, USA (5)

Tags

xref:PubMed:41347018 (1)

Previous page
1 / 455
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 455
Next page

Sort by:

Relevance

Page size

Online-2D nanoLC-MS for crude serum proteome profiling: assessing sample preparation impact on proteome composition

Although current LC-MS technology permits scientists to efficiently screen clinical samples in translational research, e.g. steroids, biogenic amines and even plasma or serum proteomes, in a daily routine, maintaining the balance between throughput and analytical depth is still a limiting factor. A ...

ORGANISM(S): Homo sapiens (Human)

2021-07-09 | PXD024893 | Pride

Ultracentrifugation versus kit exosome isolation: nanoLC-MS and other tools reveal similar performance biomarkers, but also contaminations.

Not available

S-EPMC6331754 | biostudies-literature

Increasing proteome coverage with offline RP HPLC coupled to online RP nanoLC-MS.

Not available

S-EPMC3703961 | biostudies-literature

Nanowell-mediated multidimensional separations combining nanoLC with SLIM IM-MS for rapid, high-peak-capacity proteomic analyses.

Not available

S-EPMC6500776 | biostudies-literature

NanoLC/ESI+ HRMS3 quantitation of DNA adducts induced by 1,3-butadiene.

Not available

S-EPMC5076477 | biostudies-literature

Deep Proteome Profiling with Reduced Carryover Using Superficially Porous Microfabricated nanoLC Columns.

Not available

S-EPMC9685595 | biostudies-literature

Bioinertization of NanoLC/MS/MS Systems by Depleting Metal Ions From the Mobile Phases for Phosphoproteomics.

Not available

S-EPMC10172917 | biostudies-literature

Multi-Omics Unveils Strain-Specific Neuroactive Metabolite Production Linked to Inflammation Modulation by Bacteroides and Their Vesicles

18 Bacteroidetes isoaltes were analyzed for their neuroactive potentail using un-targeted and targeted metabolomics. The bacteria were grown to stationary phase, the supernatant was separated and purified using 0.22 um filter. The metabolome from the supernatant was extracted using standard Metha...

2025-08-12 | MTBLS10526 | MetaboLights

Proteomic Analysis of Single Mammalian Cells Enabled by Microfluidic Nanodroplet Sample Preparation and Ultrasensitive NanoLC-MS.

Not available

S-EPMC6261339 | biostudies-literature

Vibrio fluvialis A8 secretome nanoLC-MS/MS

Vibrio fluvialis A8 was a newly isolated strain that possessed a good agarase production ability. The Secretomic analysis using nanoLC-MS/MS was performed to study the molecular properties including molecular weight, pI and relative abundance of the agarases in the secretome of this strain.

ORGANISM(S): Vibrio fluvialis

2020-07-30 | PXD019302 | Pride

Vibrio fluvialis a8 secretome nanolc-ms/ms

Previous page
1 / 455
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 455
Next page

Sort by:

Relevance

Page size

4541 Results

Show results for

Organisms

Organisms

Repository

Tissue

Disease

Technology Type

Instrument Platform

Publication Date

UNIPROT ID/AC

CHEBI ID

Metabolite Name

First Public Date

Modification

Study type

Release Date

Lab affiliation

Tags

OmicsDI is part of the ELIXIR infrastructure

Tweets